Newcleo advances MOX fuel licensing in France with ASNR approval
Newcleo secured a positive safety opinion from the French Nuclear Safety and Radiation Protection Authority (ASNR) for its planned MOX fuel facility, confirming that proposed provisions meet regulatory objectives. The company will incorporate recommendations for a future construction license application while continuing collaboration with French authorities and a public debate on its projects.

*this image is generated using AI for illustrative purposes only.
Newcleo, a pioneer in advanced modular reactor (AMR) technology and nuclear fuel manufacturing, has achieved a significant regulatory milestone for its planned mixed-oxide (MOX) fuel facility in France. The French Nuclear Safety and Radiation Protection Authority (ASNR) published its opinion on July 13, 2026, concluding that the safety provisions proposed by the company are satisfactory at this stage. This development marks a critical step in Newcleo's efforts to establish a first-of-a-kind MOX fuel manufacturing facility in the country.
ASNR Safety Opinion
The ASNR reviewed the safety approach dossier submitted by Newcleo in December 2024. The regulator concluded that the provisions proposed for the facility’s safety demonstrations are capable of meeting the objectives established under the applicable French nuclear safety framework. While the opinion identifies areas for further development, Newcleo intends to incorporate these recommendations into the facility design to support a future construction license application.
France 2030 Program Transition
Following an evaluation of Newcleo's application for Phase 2 of the France 2030 innovative reactor program, the General Secretariat for Investments (SGPI) determined that the company has surpassed the program's scope. Since joining the program, Newcleo has raised a significant amount of capital and achieved a substantial international presence. On May 27, 2026, the company entered into a definitive agreement for a business combination with NewHold Investment Corp. III (NASDAQ: NHIC), valuing Newcleo at a pre-money equity value of approximately $2.4 billion.
Future Collaboration
As a result of these developments, the French State will continue working with Newcleo through alternative forms of cooperation. This includes licensing support with the ASNR, engagement with state services regarding proposed projects in France, and export-facing initiatives. The company is also progressing through a similar regulatory process for its Lead-Cooled Fast Reactor (LFR) design and is currently awaiting the ASNR's opinion on its proposed safety features.
Stakeholder Engagement
In parallel with regulatory advancements, Newcleo is conducting a three-month public debate on its proposed French LFR and MOX fuel facility projects. This initiative makes Newcleo the first private developer of an innovative reactor technology to complete this key stage of stakeholder engagement in France. The company will assess the conclusions of the National Commission for the Public Debate to refine its ongoing development and planning.
| Milestone | Date/Status | Details |
|---|---|---|
| ASNR Opinion Published | July 13, 2026 | Safety approach deemed satisfactory |
| Safety Dossier Submitted | December 2024 | Submitted for MOX fuel facility |
| Business Combination Agreement | May 27, 2026 | With NewHold Investment Corp. III |
| Public Debate | Ongoing | Three-month duration for LFR and MOX projects |
How will the transition out of the France 2030 program impact the timeline for securing the final construction license for the MOX fuel facility?
What specific export-facing initiatives will the French State prioritize with Newcleo following the termination of the France 2030 funding agreement?
Will the successful safety opinion for the MOX facility accelerate the ASNR's ongoing review of Newcleo's Lead-Cooled Fast Reactor design?


























